Grand Valley State University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Grand Valley State University sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 2 currently recruiting 7 completed top decile by trial count

Grand Valley State University: 11 sponsored US clinical trials, 2 recruiting.

Grand Valley State University sponsors 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Cerebral Palsy, with 4 trials.

Top-decile sponsor footprint

Grand Valley State University ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Grand Valley State University pipeline

2 recruiting of 11 indexed (18% open); 7 completed (64%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cerebral Palsy (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Grand Valley State University: open-pipeline peers nationwide

Peers matched on 11 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Grand Valley State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10152025 0%5%10%15%20% Total trials Recruiting share Grand Valley State UniversityAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeBurke Medical Research InstituteImunonInventisBio Co.Kansas State University
Grand Valley State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Grand Valley State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this Grand Valley State University page

11 registered trials is a research-attention snapshot, not an endorsement of Grand Valley State University or any single study.

  • 2 of Grand Valley State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cerebral Palsy is the condition Grand Valley State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cerebral Palsy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Grand Valley State University pipeline card: 11 registered trials from official public datasets.Report a data error.